Frequently Asked Questions
The market is segmented based on The was valued at USD 286.31 million in 2023. The market size is projected to grow at a CAGR of 4.40% and reach USD 404.06 million by 2031.
.
The Global Peripheral Neuropathy Market size was valued at USD 286.31 USD Million in 2023.
The Global Peripheral Neuropathy Market is projected to grow at a CAGR of 4.4% during the forecast period of 2024 to 2031.
The major players operating in the market include Teikoku Pharma, Sun Pharmaceutical Industries, Galen Limited, Cipher Pharmaceuticals, Mylan, Aurobindo Pharma, ZydusCadila, Hikma Pharmaceuticals, ACI Limited, Apotex, Johnson & Johnson Services, Pfizer, Arbor Pharmaceuticals, ALMATICA PHARMA, Alkem Labs, Amneal Pharmaceuticals, Novartis, Lupin.
